Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Larney

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
JAMA Network Open|August 10, 2023
Five-Year Trajectories of Prescription Opioid UseNatasa Gisev, Luke Buizen, Ria E Hopkins, et al.
Harm Reduction Journal|May 15, 2024
The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysisSanjana Mitra, Zachary Bouck, Sarah Larney, et al.
The International Journal on Drug Policy|January 18, 2020
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalenceSarah Larney, Janni Leung, Jason Grebely, et al.
The Lancet. Global Health|October 28, 2017
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewLouisa Degenhardt, Amy Peacock, Samantha Colledge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2020
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysisJason Grebely, Lucy Tran, Louisa Degenhardt, et al.
The Lancet. Psychiatry|February 28, 2021
Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysisJack Stone, Louisa Degenhardt, Jason Grebely, et al.
Journal of Viral Hepatitis|August 9, 2019
Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
Addiction (Abingdon, England)|November 3, 2020
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysisClaire F Ferraro, Daniel E Stewart, Jason Grebely, et al.
The International Journal on Drug Policy|November 25, 2025
A scoping review and concept analysis to inform Canada's safe(r) opioid supply research agendaUyen Do, Sarah Larney, Matthew Bonn, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
JAMA Network Open|August 10, 2023
Five-Year Trajectories of Prescription Opioid UseNatasa Gisev, Luke Buizen, Ria E Hopkins, et al.
Harm Reduction Journal|May 15, 2024
The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysisSanjana Mitra, Zachary Bouck, Sarah Larney, et al.
The International Journal on Drug Policy|January 18, 2020
Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalenceSarah Larney, Janni Leung, Jason Grebely, et al.
The Lancet. Global Health|October 28, 2017
Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic reviewLouisa Degenhardt, Amy Peacock, Samantha Colledge, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2020
Association Between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysisJason Grebely, Lucy Tran, Louisa Degenhardt, et al.
The Lancet. Psychiatry|February 28, 2021
Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysisJack Stone, Louisa Degenhardt, Jason Grebely, et al.
Journal of Viral Hepatitis|August 9, 2019
Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
The Lancet. Gastroenterology & Hepatology|April 15, 2019
The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling studyAdam Trickey, Hannah Fraser, Aaron G Lim, et al.
Addiction (Abingdon, England)|November 3, 2020
Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysisClaire F Ferraro, Daniel E Stewart, Jason Grebely, et al.
The International Journal on Drug Policy|November 25, 2025
A scoping review and concept analysis to inform Canada's safe(r) opioid supply research agendaUyen Do, Sarah Larney, Matthew Bonn, et al.
Pageof 19